Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/deletion-mutants-of-human-deoxycytidine-kinase-mrna-in-cells-resistant-WD7jUH4nLU
References (23)
-
V. Haperen, G. Veerman, S. Eriksson, E. Boven, A. Stegmann, M. Hermsen, J. Vermorken, H. Pinedo, G. Peters (1994)
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.Cancer research, 54 15
-
A. Matsuda, Y. Nakajima, A. Azuma, M. Tanaka, Takuma Sasaki (1992)
Nucleosides and Nucleotides. Part 100. 2′-C-Cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine (CNDAC): Design of a Potential Mechanism- Based DNA-Strand-Breaking Antineoplastic Nucleoside.ChemInform, 23
-
Y. Hirose, H. Enei, H. Shibai (1979)
Nucleosides and Nucleotides, 3
-
E. Chottiner, D. Shewach, N. Datta, Elizabeth Ashcraft, D. Gribbin, David Ginsburg, Irving Fox, Beverly Mitchell (1991)
Cloning and expression of human deoxycytidine kinase cDNA.Proceedings of the National Academy of Sciences of the United States of America, 88
-
K. Takenuki, A. Matsuda, T. Ueda, T. Sasaki, A. Fujii, K. Yamagami (1988)
Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine.Journal of medicinal chemistry, 31 6
-
小幡徹 (1998)
Development and biochemical characterization of a 2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofuranosylcytosine(CNDAC)-resistant variant of the human fibrosarcoma cell line HT-1080(新規抗腫瘍性ヌクレオシド,2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofurano-sylcytosine(CNDAC)に対するヒト線維肉腫細胞HT-1080の耐性細胞の樹立とその生物学的特性) -
Matsuda (1995)
2′-C-Cyano-2′-deoxy-l-β-D-arabinofuranosylcytosine (CNDAC): a mechanism-based DNA-strand-breaking antitumor nucleosideJ.Med. Chem., 14
-
Y. Goan, Bingsen Zhou, E. Hu, Shu Mi, Y. Yen (1999)
Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line.Cancer research, 59 17
-
A. Matsuda, A. Azuma (1995)
2′-C-Cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine (CNDAC): A Mechanism-Based DNA-Strand-Breaking Antitumor Nucleoside1Nucleosides, Nucleotides & Nucleic Acids, 14
-
A. Azuma, Y. Nakajima, N. Nishizono, N. Minakawa, M. Suzuki, K. Hanaoka, T. Kobayashi, M. Tanaka, T. Sasaki, A. Matsuda (1993)
Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.Journal of medicinal chemistry, 36 26
-
M. Tanaka, A. Matsuda, T. Terao, T. Sasaki (1992)
Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.Cancer letters, 64 1
-
H. Uchida, Y. Chen, H. Morinaga, Y. Hayashi, A. Matsuda, T. Obata, Y. Endo, T. Sasaki (1999)
Isolation of deoxycytidine kinase from Ehrlich carcinoma cells by affinity chromatography based on a substrate analog, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-N4-palmitoylcytosine++ +.Biological & pharmaceutical bulletin, 22 1
-
Kenji Hanaoka, Masako Suzuki, Tomowo Kobayashi, Fumie Tanzawa, Kazuo Tanaka, T. Shibayama, Shinichi Miura, Tomoko Ikeda, H. Iwabuchi, Akihiko Nakagawa, Y. Mitsuhashi, Masashi Hisaoka, M. Kaneko, A. Tomida, Y. Wataya, T. Nomura, T. Sasaki, A. Matsuda, T. Tsuruo, S. Kurakata (1999)
Antitumor activity and novel DNA‐self‐strand‐breaking mechanism of CNDAC (1‐(2‐C‐cyano‐2‐deoxy‐β‐d‐ARABINO‐Pentofuranosyl) cytosine) and its N4‐palmitoyl derivative (CS‐682)International Journal of Cancer, 82
-
M. Flasshove, D. Strumberg, L. Ayscue, B. Mitchell, C. Tirier, W. Heit, S. Seeber, J. Schütte (1994)
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.Leukemia, 8 5
-
J. Carmichael, W. Degraff, A. Gazdar, J. Minna, James Mitchell (1987)
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.Cancer research, 47 4
-
(1994)
and resistance to cytosine arabino - side -
K. Yamagami, A. Fujii, M. Arita, T. Okumoto, S. Sakata, A. Matsuda, T. Ueda, T. Sasaki (1991)
Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.Cancer research, 51 9
-
Obata (1998)
Development and biochemical characterization of a 2′-C-cyano-2′-deoxy-1 -β-D-arabino-pentofuranosylcytosine (CNDAC)-resistant variant of the human fibrosarcoma cell line HT-1080Cancer Lett., 123
-
Ralf Grunewald, H. Kantarjian, Michael Keating, J. Abbruzzese, Peter Tarassoff, William Plunkett (1990)
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.Cancer research, 50 21
-
A. Matsuda, Y. Nakajima, A. Azuma, Motohiro Tanaka, Takuma Sasaki (1991)
Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.Journal of medicinal chemistry, 34 9
-
M. Veuger, M. Honders, J. Landegent, Roel Willemze, R. Barge (2000)
High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia.Blood, 96 4
-
J. Owens, D. Shewach, B. Ullman, B. Mitchell (1992)
Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.Cancer research, 52 9
-
K. Miura, M. Shiga, T. Ueda (1973)
Nucleosides and nucleotides. VI. Preparation of diribonucleoside monophosphates containing 4-thiouridine.Journal of biochemistry, 73 6
- Publisher
- Wiley
- Copyright
- Copyright © 2001 Wiley Subscription Services, Inc., A Wiley Company
- eISSN
- 1349-7006
- DOI
- 10.1111/j.1349-7006.2001.tb01163.x
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Cancer Science – Wiley
Published: Jul 1, 2001
Keywords: ; ; ;